| Name | Eligibility | More information |
|---|---|---|
| Adult and Juvenile Myositis | Adults and children with DM, PM, sIBM, and related conditions | More details; NIH – Adam Schiffenbauer 301-451-6270 NCT00017914 |
| Environmental risk factors for antisynthetase syndrome | Adults and children with myositis, with or without ASyS autoantibodies | More details; NIH – Adam Schiffenbauer 301-451-6270 NCT00017914 |
| Evaluation of clinical responsiveness of DM using cutaneous DM diseases area and severity index (CDASI) | Adults with DM and skin disease | More details; Victoria Werth 215-615-2940 NCT02945345 |
| IBM disease registry at Yale | Adults with IBM | More details; Kurt Petschke 203-785-6453 |
| IBM Natural History Study (INSPIRE-IBM) | Adults > 40 y/o with IBM | More details; NIH – Tahseen Mozaffar 714-456-2525 NCT05046821 |
| Natural history of autoinflammation diseases and JDM | Children and adults > 2 y/o with autoimmune disease, including JDM | More details; NIH – Hanna Kim 301-594-6196 NCT00059748 |
| Rheumatology patient registry and biorepository | Adults with rheumatic autoimmune disease | More details; Nicolas Page 203-737-5571 NCT04402086 |
| Study and treatment of inflammatory muscle diseases | Adults and children > 16 y/o with IMM (suspected or confirmed) | More details; NIH – Andrew Mammen 301-480-3191 NCT00001265 |